GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kilitch Drugs (India) Ltd (NSE:KILITCH) » Definitions » Cyclically Adjusted PS Ratio

Kilitch Drugs (India) (NSE:KILITCH) Cyclically Adjusted PS Ratio : 5.82 (As of Dec. 13, 2024)


View and export this data going back to 2010. Start your Free Trial

What is Kilitch Drugs (India) Cyclically Adjusted PS Ratio?

As of today (2024-12-13), Kilitch Drugs (India)'s current share price is ₹323.20. Kilitch Drugs (India)'s Cyclically Adjusted Revenue per Share for the fiscal year that ended in Mar24 was ₹55.55. Kilitch Drugs (India)'s Cyclically Adjusted PS Ratio for today is 5.82.

The historical rank and industry rank for Kilitch Drugs (India)'s Cyclically Adjusted PS Ratio or its related term are showing as below:

NSE:KILITCH' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 2   Med: 4.04   Max: 6.79
Current: 6.07

During the past 13 years, Kilitch Drugs (India)'s highest Cyclically Adjusted PS Ratio was 6.79. The lowest was 2.00. And the median was 4.04.

NSE:KILITCH's Cyclically Adjusted PS Ratio is ranked worse than
82.81% of 640 companies
in the Drug Manufacturers industry
Industry Median: 2.555 vs NSE:KILITCH: 6.07

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Kilitch Drugs (India)'s adjusted revenue per share data of for the fiscal year that ended in Mar24 was ₹96.432. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is ₹55.55 for the trailing ten years ended in Mar24.

Shiller PE for Stocks: The True Measure of Stock Valuation


Kilitch Drugs (India) Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Kilitch Drugs (India)'s Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kilitch Drugs (India) Cyclically Adjusted PS Ratio Chart

Kilitch Drugs (India) Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.81 2.55 4.29 3.03 7.00

Kilitch Drugs (India) Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 7.00 - -

Competitive Comparison of Kilitch Drugs (India)'s Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Kilitch Drugs (India)'s Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kilitch Drugs (India)'s Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kilitch Drugs (India)'s Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Kilitch Drugs (India)'s Cyclically Adjusted PS Ratio falls into.



Kilitch Drugs (India) Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Kilitch Drugs (India)'s Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=323.20/55.55
=5.82

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kilitch Drugs (India)'s Cyclically Adjusted Revenue per Share for the fiscal year that ended in Mar24 is calculated as:

For example, Kilitch Drugs (India)'s adjusted Revenue per Share data for the fiscal year that ended in Mar24 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar24 (Change)*Current CPI (Mar24)
=96.432/153.0345*153.0345
=96.432

Current CPI (Mar24) = 153.0345.

Kilitch Drugs (India) Annual Data

Revenue per Share CPI Adj_RevenuePerShare
201503 14.381 97.163 22.651
201603 15.861 102.518 23.677
201703 20.526 105.196 29.860
201803 35.444 109.786 49.406
201903 55.484 118.202 71.834
202003 31.867 124.705 39.106
202103 44.011 131.771 51.113
202203 72.567 138.822 79.996
202303 89.114 146.865 92.858
202403 96.432 153.035 96.432

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Kilitch Drugs (India)  (NSE:KILITCH) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Kilitch Drugs (India) Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Kilitch Drugs (India)'s Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Kilitch Drugs (India) Business Description

Traded in Other Exchanges
Address
Waman Tukaram Patil Marg, 37/39, Ujagar Industrial Estate, Deonar, Mumbai, MH, IND, 400 088
Kilitch Drugs (India) Ltd is an India-based pharmaceutical company. It is engaged in the manufacture and sales of pharmaceutical products. The company offers parenteral and nasal products, oral formulations, effervescent tablets, nutritional products, medical devices, and cosmetic and health products. Some of the products offered by the company are Roipar, Roivit, PH-7, C-Seal, SRO kit, 9-VIT, HPURE, and others. The company has one reportable segment, which is the development and operations of the Pharmaceutical business.

Kilitch Drugs (India) Headlines

No Headlines